Adverse reaction from topical exposure to muromonab-CD3.
Byerly
W G
WG
Winslow
R
R
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology; D003877:Dermatitis, Contact / Q000209:etiology*; D009783:Dermatitis, Occupational / Q000209:etiology*; D004155:Diphenhydramine / Q000627:therapeutic use; D006801:Humans; D016853:Muromonab-CD3
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D004155:Diphenhydramine